Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-03 5:44 pm Purchase | 2024-03-25 | 13G | Bio-Path Holdings, Inc. BPTH | Mitchell P. Kopin | 53,700 7.100% | 53,700 (New Position) | Filing History |
| 2024-03-21 4:42 pm Purchase | 2024-03-12 | 13G | ASLAN Pharmaceuticals Limited ASLN | Mitchell P. Kopin | 3,125,000 4.400% | 3,125,000 (New Position) | Filing History |
| 2024-03-14 5:10 pm Purchase | 2024-03-04 | 13G | Bone Biologics Corporation BBLG | Mitchell P. Kopin | 16,601 9.990% | 16,601 (New Position) | Filing History |
| 2024-03-06 4:09 pm Purchase | 2024-02-26 | 13G | Aclarion, Inc. ACON | Mitchell P. Kopin | 38 4.990% | 38 (New Position) | Filing History |
| 2024-03-01 4:28 pm Purchase | 2024-02-22 | 13G | Venus Concept Inc. VERO | Mitchell P. Kopin | 29,160 4.990% | 29,160 (New Position) | Filing History |
| 2024-02-12 06:16 am Purchase | 2024-02-02 | 13G | Nuvve Holding Corp. NVVE | Mitchell P. Kopin | 1,027 8.900% | 1,027 (New Position) | Filing History |
| 2024-02-06 11:12 am Purchase | 2023-12-31 | 13G | Baudax Bio, Inc. BXRXQ | Mitchell P. Kopin | 814,383 1.800% | 787,291 (+2905.99%) | Filing History |
| 2024-02-06 10:30 am Purchase | 2023-12-31 | 13G | OCEANPAL INC PAR $0.01 OPXXXX | Mitchell P. Kopin | 105,655 1.400% | 105,655 (New Position) | Filing History |
| 2024-02-06 10:30 am Purchase | 2023-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO | Mitchell P. Kopin | 99,045 9.990% | 99,045 (New Position) | Filing History |
| 2024-02-06 10:29 am Purchase | 2023-12-31 | 13G | Palisade Bio, Inc. PALI | Mitchell P. Kopin | 12,035 1.900% | 3,296 (+37.72%) | Filing History |
| 2024-02-06 10:27 am Sale | 2023-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Mitchell P. Kopin | 13,012 1.500% | -6,185 (-32.22%) | Filing History |
| 2024-02-06 10:24 am Unchanged | 2023-12-31 | 13G | NAYA Biosciences, Inc. NAYA | Mitchell P. Kopin | 15,333 6.900% | 0 (Unchanged) | Filing History |
| 2024-02-06 10:24 am Purchase | 2023-12-31 | 13G | Performance Shipping Inc. PSHG | Mitchell P. Kopin | 472,800 3.900% | 206,134 (+77.30%) | Filing History |
| 2024-02-06 10:23 am Sale | 2023-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Mitchell P. Kopin | 6,191 6.600% | -495 (-7.40%) | Filing History |
| 2024-02-06 10:22 am Purchase | 2023-12-31 | 13G | Solana Company HSDT | Mitchell P. Kopin | 1 0.100% | 1 (New Position) | Filing History |
| 2024-02-06 10:19 am Purchase | 2023-12-31 | 13G | Guardion Health Sciences, Inc. GHSI | Mitchell P. Kopin | 50,000 3.800% | 50,000 (New Position) | Filing History |
| 2024-02-06 10:17 am Sale | 2023-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 54 6.200% | -23 (-29.66%) | Filing History |
| 2024-02-06 10:16 am Purchase | 2023-12-31 | 13G | Synaptogenix, Inc. SNPX | Mitchell P. Kopin | 41,929 4.990% | 10,460 (+33.24%) | Filing History |
| 2024-02-06 10:14 am Purchase | 2023-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Mitchell P. Kopin | 23,961 0.900% | 23,961 (New Position) | Filing History |
| 2024-02-06 10:12 am Unchanged | 2023-12-31 | 13G | Tian Ruixiang Holdings Ltd TIRX | Mitchell P. Kopin | 10,733 8.100% | 0 (Unchanged) | Filing History |